Patient info Open main menu

Flixotide 250 micrograms Evohaler,Fluticasone Propionate 250 micrograms inhaler – Summary of Product Characteristics (SmPC) for healthcare professionals

Medicine status: No longer supplied Details

Medicine strength:
250 micrograms
Contains active substance:

Summary of Product Characteristics (SmPC) - Flixotide 250 micrograms Evohaler,Fluticasone Propionate 250 micrograms inhaler

Facts about Flixotide 250 micrograms Evohaler,Fluticasone Propionate 250 micrograms inhaler

Active substance Fluticasone
Strength 250 micrograms
Is it available? No, all its packs are listed as discontinued (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Drug group (ATC)
  1. R Respiratory system drugs
    1. R03 Drugs for obstructive airway diseases
      1. R03B Other drugs for obstructive airway diseases, inhalants
        1. R03BA Glucocorticoid inhalants for obstructive airway disease
          1. R03BA05 fluticasone

Sources: the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.